- Home
- ABEO vs MTRX Comparison
ABEO vs MTRX Comparison
Compare ABEO & MTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- MTRX
- Stock Information
- Founded
- ABEO N/A
- MTRX 1984
- Country
- ABEO United States
- MTRX United States
- Employees
- ABEO N/A
- MTRX N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- MTRX Engineering & Construction
- Sector
- ABEO Health Care
- MTRX Consumer Discretionary
- Exchange
- ABEO Nasdaq
- MTRX Nasdaq
- Market Cap
- ABEO 277.6M
- MTRX 293.9M
- IPO Year
- ABEO 1980
- MTRX 1990
- Fundamental
- Price
- ABEO $5.86
- MTRX $12.52
- Analyst Decision
- ABEO Strong Buy
- MTRX Strong Buy
- Analyst Count
- ABEO 3
- MTRX 1
- Target Price
- ABEO $18.00
- MTRX $18.00
- AVG Volume (30 Days)
- ABEO 292.3K
- MTRX 124.4K
- Earning Date
- ABEO 11-14-2024
- MTRX 11-06-2024
- Dividend Yield
- ABEO N/A
- MTRX N/A
- EPS Growth
- ABEO N/A
- MTRX N/A
- EPS
- ABEO N/A
- MTRX N/A
- Revenue
- ABEO N/A
- MTRX $696,133,000.00
- Revenue This Year
- ABEO N/A
- MTRX $28.10
- Revenue Next Year
- ABEO $7,097.06
- MTRX $13.85
- P/E Ratio
- ABEO N/A
- MTRX N/A
- Revenue Growth
- ABEO 147.52
- MTRX N/A
- 52 Week Low
- ABEO $3.05
- MTRX $8.61
- 52 Week High
- ABEO $9.01
- MTRX $13.90
- Technical
- Relative Strength Index (RSI)
- ABEO 38.62
- MTRX 58.74
- Support Level
- ABEO $5.95
- MTRX $12.65
- Resistance Level
- ABEO $6.78
- MTRX $13.24
- Average True Range (ATR)
- ABEO 0.32
- MTRX 0.52
- MACD
- ABEO -0.07
- MTRX 0.08
- Stochastic Oscillator
- ABEO 7.07
- MTRX 64.63
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About MTRX Matrix Service Company
Matrix Service Co is an engineering and construction provider for large industrial projects, primarily in the oil and gas, power, petrochemical, industrial, mining, and minerals markets. It offers engineering, fabrication, construction, and maintenance services, operating across three segments namely Utility and Power Infrastructure; Process and Industrial Facilities and Storage and Terminal Solutions.